Diabetes

The American Diabetes Association and YMCA of the USA (Y-USA), in collaboration with the American Medical Association (AMA), released important new research today examining HR 962/S 452, the Medicare Diabetes Prevention Act (MDPA). The study, Estimated Federal Impact of the Medicare Diabetes Prevention Act, conducted by Avalere Health, was commissioned by the three organizations to identify the federal government savings or cost burden of the legislation using methods similar to those of the Congressional Budget Office (CBO). The research estimates the legislation would reduce federal spending by $1.3 billion over the 10-year budget window (2015-2024) and also reduce the incidence of diabetes among seniors.

Obesity

The Trust for America’s Health (TFAH) and the Robert Wood Johnson Foundation (RWJF) recently issued their report on the state of obesity in America and there is enough good news in the report to view it as a glass half full. Unfortunately, the warning signs in the report are so serious that the glass may actually be half-full with a double-thick chocolate shake topped with extra whipped cream and a candy bar on the side.

Heart Disease

Medicare Part D has had important implications for patient outcomes and treatment costs among beneficiaries with congestive heart failure (CHF). This study finds that improved medication adherence associated with expansion of drug coverage under Part D led to nearly $2.6 billion in reductions in medical expenditures annually among beneficiaries diagnosed with CHF and without prior comprehensive drug coverage, of which over $2.3 billion was savings to Medicare. Further improvements in adherence could potentially save Medicare another $1.9 billion annually, generating upwards of $22.4 billion in federal savings over 10 years.